National International Holding Company K.S.C.P. (KWSE:NIH)

KWSE:NIH Income Statement

Financials in millions KWD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Revenue	4.06	4.04	4.46	4.32	3.34
Other Revenue	2.52	4.13	3.49	2.52	2.51
Revenue	6.58	8.18	7.95	6.84	5.85
Revenue Growth (YoY)	-19.50%	2.82%	16.25%	16.92%	3620.84%
Cost of Revenue	2.93	2.94	3.39	3.39	2.39
Gross Profit	3.65	5.23	4.56	3.45	3.46
Selling, General & Admin	1.76	1.6	1.73	1.57	1.53
Other Operating Expenses	0.03	0.03	0.03	0	-0.07
Operating Expenses	1.83	1.63	1.75	1.58	1.46
Operating Income	1.82	3.61	2.8	1.87	1.99
Interest Expense	-0.22	-0.22	-0.24	-0.16	-0.14
Other Non Operating Income (Expenses)	-0.01	-0	-0	-	-0
EBT Excluding Unusual Items	1.59	3.38	2.56	1.71	1.85
Gain (Loss) on Sale of Investments	-	-1.52	-	-	-
Gain (Loss) on Sale of Assets	-	-	-	-0.01	-0.05
Asset Writedown	0.31	-	-	-	-0
Pretax Income	1.9	1.87	2.56	1.7	1.8
Income Tax Expense	0.01	0.01	0.01	0	0
Earnings From Continuing Operations	1.89	1.86	2.55	1.7	1.8
Minority Interest in Earnings	0.02	-0.22	-0.28	0.03	-0
Net Income	1.91	1.64	2.28	1.72	1.79
Net Income to Common	1.91	1.64	2.28	1.72	1.79
Net Income Growth	16.21%	-28.04%	32.36%	-4.03%	-
Shares Outstanding (Basic)	246	243	242	231	224
Shares Outstanding (Diluted)	246	243	242	231	224
Shares Change (YoY)	1.03%	0.29%	5.02%	2.86%	-2.25%
EPS (Basic)	0.01	0.01	0.01	0.01	0.01
EPS (Diluted)	0.01	0.01	0.01	0.01	0.01
EPS Growth	15.02%	-28.25%	26.03%	-6.69%	-
Free Cash Flow	1.86	-1.19	-0.4	-0.85	0.91
Free Cash Flow Per Share	0.01	-0.01	-0.00	-0.00	0.00
Dividend Per Share	0.002	-	0.006	0.005	0.005
Dividend Growth	-	-	21.28%	2.17%	-
Gross Margin	55.45%	64.01%	57.31%	50.37%	59.08%
Operating Margin	27.64%	44.10%	35.25%	27.32%	34.10%
Profit Margin	28.95%	20.06%	28.66%	25.17%	30.66%
Free Cash Flow Margin	28.28%	-14.50%	-5.06%	-12.47%	15.49%
EBITDA	1.95	3.78	2.89	2.05	2.13
EBITDA Margin	29.70%	46.29%	36.41%	29.97%	36.43%
D&A For EBITDA	0.14	0.18	0.09	0.18	0.14
EBIT	1.82	3.61	2.8	1.87	1.99
EBIT Margin	27.64%	44.10%	35.25%	27.32%	34.10%
Effective Tax Rate	0.34%	0.30%	0.24%	0.00%	0.15%
Revenue as Reported	6.89	8.18	7.95	6.83	5.88

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.